X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
USA (Orange Book)
Europe
0
Canada
0
Australia
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
0
0
http://www.pharmafile.com/news/606044/smc-approves-diroximel-fumarate-multiple-sclerosis-treatment
https://www.pharmatimes.com/news/mhra_authorises_vumerity_for_multiple_sclerosis_patients_1383757
https://www.europeanpharmaceuticalreview.com/news/165570/european-commission-grants-marketing-authorisation-for-vumerity/
https://www.globenewswire.com/news-release/2021/11/16/2335494/0/en/The-European-Commission-Grants-Marketing-Authorization-for-VUMERITY-diroximel-fumarate-as-Oral-Treatment-for-Relapsing-Remitting-Multiple-Sclerosis.html
https://www.globenewswire.com/news-release/2021/10/13/2313235/0/en/New-Data-at-ECTRIMS-2021-Highlight-Biogen-s-Focus-on-Patient-Centered-Outcomes-and-Improving-the-MS-Patient-Experience.html
https://www.raps.org/news-and-articles/news-articles/2021/9/euro-roundup-chmp-recommends-drugs-from-biogen-and
https://www.globenewswire.com/news-release/2021/09/17/2299130/0/en/CHMP-Recommends-VUMERITY-diroximel-fumarate-for-Approval-in-the-European-Union-as-a-Treatment-for-Relapsing-Remitting-Multiple-Sclerosis.html
https://www.fiercepharma.com/pharma/biogen-s-vumerity-stalled-by-pandemic-faces-a-critical-stretch-ahead
https://www.contractpharma.com/contents/view_breaking-news/2019-11-12/alkermes-receives-150m-biogen-milestone/
https://www.pharmaceutical-technology.com/news/fda-vumerity-relapsing-ms/
https://endpts.com/biogen-alkermes-win-fda-approval-of-tecfidera-successor-but-can-they-actually-sell-it/
https://seekingalpha.com/news/3506769-alkermes-plus-1_5-percent-tentative-vumerity-approval
http://www.pmlive.com/pharma_news/biogen_trumpets_safety_data_for_tecfidera_follow-up_1289548
https://www.prnewswire.com/news-releases/alkermes-and-biogen-announce-us-food-and-drug-administration-acceptance-of-diroximel-fumarate-new-drug-application-for-multiple-sclerosis-300800855.html
http://www.pharmatimes.com/news/alkermes_and_biogen_announce_new_ms_drug_application_for_fda_1272962
Market Place
Share 
